Occurence of Cutaneous Marginal Zone B-Cell Lymphoma Post Breast Cancer Chemotherapy: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Primary cutaneous marginal zone B-cell lymphomas (PCMZLs) are classified as low- grade as they run an indolent course. They are histologically characterized through non- epidermotropic nodular or diffuse infiltrates consisting of small or medium heterogeneous atypical lymphoid cells. In the past few years, chemotherapy has increased the survival rate of breast cancer patients. However, the adverse effects of treatment, such as leukemia, have also been shown to emerge gradually. Additionally, cases of occurrence of non-Hodgkin lymphoma (NHL) post chemotherapy have also been reported. A 48-year-old female patient was presented with a violaceous nodule on her left thigh. Around 15 months ago, she com- pleted breast cancer chemotherapy. Eight months later, a skin lesion appeared. Histological findings revealed dense and nodular lymphocyte infiltration. Immunohistochemical stain- ing was positive for CD20 and BCL2. Clinical and histological examination of the lesions confirmed PCMZL. After systemic evaluation, lymphoma was found to be limited to the skin, and thus, she underwent complete excision of the lesion. At the first month follow- up, there was a recurrent lesion on the right wrist, which was excised successfully. However, recurrences occurred again in the calf and forearm in the following five and two months, respectively. These lesions were also confirmed with PCMZL using biopsy. We assume that this case is related to chemotherapy as it was presented and recurred abruptly post chemo- therapy. Additionally, there are several reported cases of NHL post breast cancer chemo- therapy. However, this is the first case report of PCMZL associated with chemotherapy.
Abstract
Primary cutaneous marginal zone B-cell lymphomas (PCMZLs) are classified as low- grade as they run an indolent course. They are histologically characterized through non- epidermotropic nodular or diffuse infiltrates consisting of small or medium heterogeneous atypical lymphoid cells. In the past few years, chemotherapy has increased the survival rate of breast cancer patients. However, the adverse effects of treatment, such as leukemia, have also been shown to emerge gradually. Additionally, cases of occurrence of non-Hodgkin lymphoma (NHL) post chemotherapy have also been reported. A 48-year-old female patient was presented with a violaceous nodule on her left thigh. Around 15 months ago, she com- pleted breast cancer chemotherapy. Eight months later, a skin lesion appeared. Histological findings revealed dense and nodular lymphocyte infiltration. Immunohistochemical stain- ing was positive for CD20 and BCL2. Clinical and histological examination of the lesions confirmed PCMZL. After systemic evaluation, lymphoma was found to be limited to the skin, and thus, she underwent complete excision of the lesion. At the first month follow- up, there was a recurrent lesion on the right wrist, which was excised successfully. However, recurrences occurred again in the calf and forearm in the following five and two months, respectively. These lesions were also confirmed with PCMZL using biopsy. We assume that this case is related to chemotherapy as it was presented and recurred abruptly post chemo- therapy. Additionally, there are several reported cases of NHL post breast cancer chemo- therapy. However, this is the first case report of PCMZL associated with chemotherapy.
참고문헌 (19)
- Willemze R, "WHO-EORTC classification for cutaneous lymphomas", Blood, 105, pp.3768~3785 (2005)
- Guidoboni M, "Infectious agents in mucosa-associated lymphoid tissue-type lymphomas : pathogenic role and therapeutic perspectives", Clin Lymphoma Myeloma, 6, pp.289~300 (2006)
- Senff NJ, "European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas", Blood, 112, pp.1600~1609 (2008)
- Servitje O, "Primary cutaneous marginal zone B-cell lymphoma : response to treatment and disease-free survival in a series of 137 patients", J Am Acad Dermatol, 69, pp.357~365 (2013)
- "Rev Invest Clin", 1992, 393~398
- Trenkner DA, "Non-Hodgkin’s lymphomas following radiation therapy alone for Hodgkin’s disease", Radiother Oncol, 6, pp.199~206 (1986)
- Heinz R, "Non-Hodgkin lymphoma following Hodgkin’s disease. A case report", Blut, 49, pp.353~357 (1984)
- O’Riordan JM, "Localized, late-onset, high-grade lymphoma following bone marrow transplantation : response to combination chemotherapy", Br J Haematol, 86, pp.183~186 (1994)
- Sandoval C, "Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation", J Clin Oncol, 11, pp.1039~1045 (1993)
- Krishnan B, "Non-Hodgkin lymphoma secondary to cancer chemotherapy", Cancer Epidemiol Biomarkers Prev, 16, pp.377~380 (2007)
- Ririe MR, "Secondary diffuse large B-cell lymphoma after chemotherapy for acute myeloid leukemia : looking for the unexpected diagnosis", Am J Dermatopathol, 36, pp.e125~e128 (2014)
- Eser B, "A case of subcutaneous panniculitis-like T-cell lymphoma with haemophagocytosis developing secondary to chemotherapy", J Eur Acad Dermatol Venereol, 18, pp.713~715 (2004)
- Zhang B, "How breast cancer chemotherapy increases the risk of leukemia : thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy", Cancer Biol Ther, 17, pp.125~128 (2016)
- Breton AL, "Primary cutaneous marginal zone lymphoma as a complication of radiation therapy : case report and review", Dermatol Online J, 16, pp.6~ (2010)
- Stein M, "Primary brain lymphoma after X-ray irradiation to the scalp for tinea capitis in childhood", J Surg Oncol, 50, pp.270~273 (1992)
- Yukiiri K, "Second primary cardiac B-cell lymphoma after radiation therapy and chemotherapy--a case report", Angiology, 52, pp.563~565 (2001)
- Wolff AC, "Risk of marrow neoplasms after adjuvant breast cancer therapy : the national comprehensive cancer network experience", J Clin Oncol, 33, pp.340~348 (2015)
- Sroa N, "Pediatric primary cutaneous marginal zone lymphoma : in association with chronic antihistamine use", J Cutan Pathol, 33(Suppl 2), pp.1~5 (2006)
- Breza TS Jr, "Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy : a hypothesis regarding pathogenesis based on in vitro suppression of T-cellproliferative response", J Cutan Pathol, 33, pp.522~528 (2006)